Gordon Cohen

Gordon Cohen is the Global Clinical Head at AstraZeneca, a position held since 2023, following their role as Global Clinical Program Lead from 2020 to 2023. Previously, they completed a fellowship in Pediatric Hematology/Oncology at Johns Hopkins Medicine and the National Institutes of Health from 2013 to 2017, and served as an Instructor of Pediatric Oncology at The Johns Hopkins University School of Medicine in 2017-2018. Gordon's diverse background includes significant experience in biotechnology equity research at firms such as Merrill Lynch and Lehman Brothers. They hold a Doctor of Medicine degree from The Johns Hopkins University School of Medicine, as well as multiple degrees in Economics and Public Health.